High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$43K
$43,004
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
PCSA
P
Processa Pharmaceuticals, Inc.
Baluch Khoso
• Director
Discretionary BuyΔOwn +4051.8%
2026-03-31
$5,752
|
||||||
| PCSA |
Processa Pharmaceuticals, Inc.
|
Director
Discretionary BuyΔOwn +4051.8%
|
2026-03-31 | $5,752 | P | Form 4 |
|
PCSA
P
Processa Pharmaceuticals, Inc.
Bigora Sian
• Officer • Chief Development Officer
Discretionary BuyΔOwn +131.4%
2026-03-31
$5,341
|
||||||
| PCSA |
Processa Pharmaceuticals, Inc.
|
Officer • Chief Development Officer
Discretionary BuyΔOwn +131.4%
|
2026-03-31 | $5,341 | P | Form 4 |
| PCSA |
Processa Pharmaceuticals, Inc.
|
Officer • Chief Administrative Officer
Discretionary BuyΔOwn +147.6%
|
2026-03-31 | $4,700 | P | Form 4 |
|
PCSA
P
Processa Pharmaceuticals, Inc.
Lin Patrick
• Officer • Chief Business - Strategy Off
Discretionary BuyΔOwn +91.4%
2026-03-31
$4,064
|
||||||
| PCSA |
Processa Pharmaceuticals, Inc.
|
Officer • Chief Business - Strategy Off
Discretionary BuyΔOwn +91.4%
|
2026-03-31 | $4,064 | P | Form 4 |
|
PCSA
P
Processa Pharmaceuticals, Inc.
Neal James R
• Director
Discretionary BuyΔOwn +2720.7%
2026-03-31
$2,000
|
||||||
| PCSA |
Processa Pharmaceuticals, Inc.
|
Director
Discretionary BuyΔOwn +2720.7%
|
2026-03-31 | $2,000 | P | Form 4 |
|
PCSA
P
Processa Pharmaceuticals, Inc.
Ng George K
• CEO
Discretionary BuyΔOwn +141.2%
2026-03-31
$5,415
|
||||||
| PCSA |
Processa Pharmaceuticals, Inc.
|
CEO
Discretionary BuyΔOwn +141.2%
|
2026-03-31 | $5,415 | P | Form 4 |
|
PCSA
P
Processa Pharmaceuticals, Inc.
Pannu Geraldine
• Director
Discretionary BuyΔOwn +1786.2%
2026-03-31
$5,253
|
||||||
| PCSA |
Processa Pharmaceuticals, Inc.
|
Director
Discretionary BuyΔOwn +1786.2%
|
2026-03-31 | $5,253 | P | Form 4 |
| PCSA |
Processa Pharmaceuticals, Inc.
|
CFO
Discretionary Buy
|
2026-03-31 | $5,891 | P | Form 4 |
|
PCSA
P
Processa Pharmaceuticals, Inc.
Young David
• Officer • Pres. Research & Development
Discretionary BuyΔOwn +20.7%
2026-03-31
$4,588
|
||||||
| PCSA |
Processa Pharmaceuticals, Inc.
|
Officer • Pres. Research & Development
Discretionary BuyΔOwn +20.7%
|
2026-03-31 | $4,588 | P | Form 4 |